Color Code
Yellow

Protective Immunity to Norovirus in Indian Cohort

884
India woman
Protective Immunity to Norovirus in Indian Cohort
India
To establish the role of norovirus as a cause of diarrheal disease and to understand the development of protective immunity in a birth cohort in India.
Christian Medical College, Vellore (Bill & Melinda Gates Foundation)
CDC’s National Center for Immunization and Respiratory Diseases

Impact Study of Rotavirus Vaccine in India

871
India children
Impact Study of Rotavirus Vaccine in India
India
To generate data on the effectiveness and impact of rotavirus vaccination in early introducing regions of India and help establish a platform for assessment of safety with respect to intussusception.
Bill & Melinda Gates Foundation
CDC's National Center for Immunizations and Respiratory Disease

Chronic Hepatitis B Virus Infection in Tanzania

880
map
Chronic Hepatitis B Virus Infection in Tanzania
Tanzania
Tanzania
To implement and evaluate the feasibility of a care and treatment model for persons infected with chronic hepatitis B virus in resource-limited settings.
Gilead Sciences
CDC’s National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention; Mnazi Mmoja Hospital; Muhimbili National Hospital

Maternal and Perinatal Death Surveillance

909
Malaysia mom and baby
Maternal and Perinatal Death Surveillance
Malaysia
To reduce maternal and perinatal death globally through strengthening implementation of Maternal and Perinatal Death Surveillance and Response (MPDSR) systems and advise WHO and partners on guidance, standards of practice and tools to help achieve the post-MDG maternal and newborn goals and targets.
World Health Organization
CDC’s National Center for Chronic Disease Prevention and Health Promotion

Evaluation of Rotavirus Vaccine in Vietnam

921
vietnam
Evaluation of Rotavirus Vaccine in Vietnam
Viet Nam
To establish rotavirus surveillance, implement rotavirus vaccination introduction and evaluate impact and effectiveness of rotavirus vaccination in targeted districts in Vietnam.
Bill & Melinda Gates Foundation
CDC’s National Center for Immunization and Respiratory Diseases; National Institute of Hygiene and Epidemiology

Malaria Zero

Malaria Zero Logo

Malaria Zero has one bold goal: to eliminate malaria from the island of Hispaniola, which includes Haiti and the Dominican Republic, by 2020. Hispaniola is the only island in the Caribbean where malaria is still endemic. Partners include the CDC Foundation, the U.S. Centers for Disease Control and Prevention, the Ministry of Public Health and Population of Haiti, the Ministry of Public Health and Social Assistance of the Dominican Republic, the Pan American Health Organization, The Carter Center, the Clinton Health Access Initiative, the London School of Hygiene & Tropical Medicine, and Tulane University School of Public Health and Tropical Medicine.

These experts have united to achieve a major milestone in global health—a malaria-free zone across the Caribbean in just a few years’ time. Working collectively with governments and organizations in Haiti and the Dominican Republic, Malaria Zero will implement an evidence-based plan to eliminate malaria by 2020 and contribute to knowledge that will support global malaria eradication.

The Bill & Melinda Gates Foundation has generously provided $29.9 million in initial funding to Malaria Zero; however, up to $70 million more is needed to achieve elimination on Hispaniola by 2020.

To learn more about Malaria Zero, visit the website at www.malariazeroalliance.org. 

For additional information about Malaria Zero, contact malariazero@cdcfoundation.org.


“Elimination of malaria transmission in Haiti, coupled with eliminating the few remaining cases in the Dominican Republic, will create a malaria-free zone across the Caribbean. This will be an historic public health milestone for the Western Hemisphere, and will greatly reduce the risk of reintroduction of malaria to nearby countries where it’s already been eliminated.”

Larry Slutsker, M.D., M.P.H.
Former Director of CDC's Division of Parasitic Diseases and Malaria

819 / 837
Malaria
Malaria Zero
Dominican Republic
Haiti
To eliminate malaria on the island of Hispaniola by 2020 by developing, adopting and implementing an evidence-based strategy and operational plan, securing resources, and improving and refining malaria surveillance systems.
Bill & Melinda Gates Foundation; multiple individual donors
CDC’s Center for Global Health; Ministry of Public Health and Population of Haiti; Ministry of Public Health and Social Assistance of the Dominican Republic; Pan American Health Organization; The Carter Center; Clinton Health Access Initiative; Tulane University School of Public Health and Tropical Medicine; London School of Hygiene & Tropical Medicine

Tobacco Control Surveillance and Capacity Building in Africa

Tobacco use is the leading cause of preventable death and disease in the world, resulting in approximately six million deaths annually. Compared to many other regions, tobacco use remains relatively low in sub-Saharan Africa, but consumption in the region is rising as tobacco companies are increasingly targeting low- and middle-income countries. It is estimated that without comprehensive tobacco use prevention and control policies, smoking prevalence in the region could rise from approximately 15 percent in 2010 to almost 22 percent in 2030.

Expanding CDC’s Global Tobacco Surveillance System

The Global Tobacco Surveillance System (GTSS), comprised of the Global Adult Tobacco Survey (GATS), the Global Youth Tobacco Survey (GYTS), and Tobacco Questions for Surveys (TQS), provides globally standardized data to track adult and youth tobacco use prevalence and trends across the world. The CDC Foundation supports the work of CDC, the World Health Organization (WHO), and other international partners in implementing and expanding select components of GTSS in sub-Saharan Africa.

Tobacco SurveillanceMany countries in sub-Saharan Africa lack comprehensive and comparable data on adult tobacco use trends and effects of tobacco use. The implementation of GATS and TQS will generate comparable data within and across countries and enhances a country’s capacity to design, implement, and evaluate tobacco control interventions.

GYTS, a school-based survey that collects data on students aged 13–15 years, is intended to enhance a country’s capacity to design, implement, and evaluate youth tobacco control and prevention programs. The collection of GYTS data will provide much needed youth tobacco use trend data for most of the African continent.

In addition to funding, the CDC Foundation provides logistical and administrative support; including, managing contracts and procurement, convening subject matter experts and partners, working with WHO and CDC to support survey implementation, and helping operationalize CDC’s vision for global tobacco surveillance.
 

Helping CDC Build Tobacco Control Capacity

The data collected through GTSS will be used to build research, epidemiology, and policy capacity in sub-Saharan Africa. The CDC Foundation supports CDC in implementing Data to Action workshops to build in-country and regional tobacco control capacity for advancing tobacco control policies, programs, and research. In addition, the facilitation of locally and regionally produced publications will enhance data analysis and research capacity in the region.

This project is supported by the Bill & Melinda Gates Foundation.

View Project Announcement

View Blog Post

808
survey
Tobacco Control Surveillance and Capacity Building
Burkina Faso
Benin
Botswana
Côte d’Ivoire
Cameroon
Algeria
Eritrea
Ethiopia
Ghana
Gambia
Mali
Mauritania
Mauritius
Niger
Nigeria
Seychelles
Sierra Leone
Chad
Togo
Tanzania
Uganda
To build and enhance tobacco use surveillance and research capacity in sub-Saharan Africa by expanding the Global Tobacco Surveillance System (GTSS). The GTSS will enable sub-Saharan African countries to produce globally standardized tobacco use data and track key tobacco control measures among the region’s adult and youth populations.
The Bill & Melinda Gates Foundation
CDC’s National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health, Global Tobacco Control Branch; World Health Organization; RTI International

Leveraging Rotavirus Networks

758
Haiti child
Leveraging Rotavirus Networks
Australia
Brazil
Ghana
India
South Africa
To determine the performance characteristics of tacrolimus-based (TAC) genotyping in comparison to conventional genotyping assays to better assess the role of different enteric pathogens in diarrhea requiring hospitalization among children less than five years of age. The technology will advance the analysis of rotavirus vaccine effectiveness studies by revealing how often cases of rotavirus vaccine failure are actually infections due to other enteric pathogens.
Bill & Melinda Gates Foundation
CDC's National Center for Immunization and Respiratory Diseases; World Health Organization; University of Virginia

MenAfriNet Meningitis Surveillance in Africa

764
MenAfriNet
MenAfriNet Meningitis Surveillance in Africa
Burkina Faso
Mali
Niger
Chad
Togo
To establish a regional surveillance network—MenAfriNet—to collect and analyze high quality case-based meningitis surveillance data from representative sites across the African meningitis belt. The meningitis surveillance network will evaluate the impact of MenAfriVac to guide research on new vaccines and strategies to optimize impact of existing vaccines.
Bill & Melinda Gates Foundation
CDC's National Center for Immunization and Respiratory Diseases; WHO-AFRO; Agence de Medicine Preventive; Ministries of Health and other non-governmental agencies

Improving Data for Global Cervical Cancer Screening and Treatment Programs

770
Kenya
Improving Data for Global Cervical Cancer Screening and Treatment Programs
Botswana, Ethiopia, Guatemala, Kenya, Tanzania, Zambia
Botswana
Ethiopia
Guatemala
Kenya
Tanzania
Zambia
To increase the availability of information on selected country programs—including readiness, opportunities and challenges—for implementation of surveillance, monitoring and evaluation of programs to screen and treat cervical cancer; and to develop a globally endorsed, standardized toolkit that can be adapted at the country level to support the collection of high-quality data for cervical cancer programs.
Bill & Melinda Gates Foundation
CDC’s Center for Global Health, Division of HIV/AIDS Prevention, National Center for HIV/AIDS, Viral Hepatitis, Sexual Transmitted Diseases and Tuberculosis Prevention, Epidemiology and Strategic Information Branch; CDC's Office of Noncommunicable Diseases, Injury and Environmental Health, National Center for Chronic Disease Prevention and Health Promotion, Division of Cancer Prevention and Control; George W. Bush Institute; World Health Organization
Subscribe to Global Health